BridgeMD
New treatment option for Elderly
Official title Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
ClinicalTrials.gov ID: NCT06824818
What this study is testing
- What it's testing
- This study seeks to identify if it is feasible to stop Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy in elderly men with prostate cancer. We hypothesize that elderly prostate cancer patients on long term androgen ablation with LHRH agonists will be permanently castrated and do not require ongoing LHRH agonist therapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 70 and older, men only
You may be able to join if
- Prostate cancer with \>3 years of LHRH agonist therapy.
- Age ≥70 years.
- ECOG performance status ≤2
- Baseline testosterone of \< 20 ng/ml
- No prior chemotherapy or Lu-PSMA (unless survival predictions are favorable).
You likely can't join if
- none
See the full eligibility criteria
- Prostate cancer with \>3 years of LHRH agonist therapy.
- Age ≥70 years.
- ECOG performance status ≤2
- Baseline testosterone of \< 20 ng/ml
- No prior chemotherapy or Lu-PSMA (unless survival predictions are favorable).
- Ability to understand and sign informed consent.
- none
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 70 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.